公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2023 | Darolutamide for non-metastatic castration-resistant prostate cancer: Efficacy, safety, and clinical perspectives of use | Yang, Cheng-Kuang; Cha, Tai-Lung; Chang, Yen-Hwa; Huang, Shu-Pin; Lin, Jen-Tai; Wang, Shian-Shiang; CHAO-YUAN HUANG ; Pang, See-Tong | Journal of the Formosan Medical Association = Taiwan yi zhi | 3 | 3 | |
2007 | Down-Regulation of Abcd1 May Be Involved in Tumorigenesis of Human Renal Cell Carcinoma | HOUR, TZYH-CHYUAN; YU, HONG-JENG; HUANG, SHU-PIN; PU, YEONG-SHIAU | FEBS JOURNAL | | | |
2024 | EGFR-mediated hyperacetylation of tubulin induced docetaxel resistance by downregulation of HDAC6 and upregulation of MCAK and PLK1 in prostate cancer cells | YEONG-SHIAU PU ; CHAO-YUAN HUANG ; Wu, Hung-Lin; Wu, Jyun-Hong; Su, Ying-Fang; Yu, Chang-Tze Ricky; Lu, Chi-Yu; Wu, Wen-Jeng; Huang, Shu-Pin; Huang, Ying-Tang; Hour, Tzyh-Chyuan | The Kaohsiung journal of medical sciences | | | |
2022 | Enzalutamide in Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer: An Asian Multiregional, Randomized Study | YEONG-SHIAU PU ; Ahn, Hanjong; Han, Weiqing; Huang, Shu-Pin; Wu, Hsi-Chin; Ma, Lulin; Yamada, Shunsuke; Suga, Kazutaka; Xie, Li-Ping | Advances in therapy | 3 | 3 | |
2022 | Genetic Analysis Implicates Dysregulation of SHANK2 in Renal Cell Carcinoma Progression | Chang, Chi-Fen; Huang, Shu-Pin; Hsueh, Yu-Mei; Geng, Jiun-Hung; CHAO-YUAN HUANG ; Bao, Bo-Ying | International journal of environmental research and public health | 1 | 0 | |
2022 | Genetic Analysis Reveals the Prognostic Significance of the DNA Mismatch Repair Gene MSH2 in Advanced Prostate Cancer | Chang, Hao-Han; Lee, Cheng-Hsueh; Chen, Yei-Tsung; CHAO-YUAN HUANG ; Yu, Chia-Cheng; Lin, Victor C; Geng, Jiun-Hung; Lu, Te-Ling; Huang, Shu-Pin; Bao, Bo-Ying | Cancers | 5 | 7 | |
2024 | Integrated analysis identifies GABRB3 as a biomarker in prostate cancer | Chen, Jun-Yan; Chang, Chi-Fen; Huang, Shu-Pin; CHAO-YUAN HUANG ; Yu, Chia-Cheng; Lin, Victor C; Geng, Jiun-Hung; Li, Chia-Yang; Lu, Te-Ling; Bao, Bo-Ying | BMC medical genomics | | | |
2022 | TNFRSF13B is a potential contributor to prostate cancer | Li, Chia-Yang; Huang, Shu-Pin; Chen, Yei-Tsung; Wu, Hsin-En; WEI-CHUNG CHENG; CHAO-YUAN HUANG ; Yu, Chia-Cheng; Lin, Victor C; Geng, Jiun-Hung; Lu, Te-Ling; Bao, Bo-Ying | Cancer cell international | 2 | 2 | |